根据ESI于2026年7月发布的数据，我校高被引论文（Highly Cited Papers）779篇，热点论文（Hot Papers）31篇，见附件：2026年7月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在779篇高被引论文中，临床医学最多（377篇），占比48.40%，药理学与毒理学60篇（7.70%）紧跟其后。
|
序号 |
高被引论文 Research Field |
2026.7 |
2026.5 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
CLINICAL MEDICINE |
377 |
48.40% |
361 |
48.13% |
|
|
2 |
MOLECULAR BIOLOGY & GENETICS |
57 |
7.32% |
54 |
7.20% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
58 |
7.45% |
55 |
7.33% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
60 |
7.70% |
56 |
7.47% |
|
5 |
MATERIALS SCIENCE |
47 |
6.03% |
44 |
5.87% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
26 |
3.34% |
27 |
3.60% |
|
7 |
ENGINEERING |
14 |
1.80% |
12 |
1.60% |
|
8 |
MICROBIOLOGY |
25 |
3.21% |
26 |
3.47% |
|
9 |
CHEMISTRY |
9 |
1.16% |
9 |
1.20% |
|
10 |
PHYSICS |
39 |
5.01% |
41 |
5.47% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
14 |
1.80% |
13 |
1.73% |
|
12 |
IMMUNOLOGY |
17 |
2.18% |
18 |
2.40% |
|
13 |
SOCIAL SCIENCES, GENERAL |
10 |
1.28% |
11 |
1.47% |
|
14 |
COMPUTER SCIENCE |
11 |
1.41% |
11 |
1.47% |
|
15 |
AGRICULTURAL SCIENCES |
4 |
0.51% |
4 |
0.53% |
|
16 |
MULTIDISCIPLINARY |
1 |
0.13% |
0 |
0.00% |
|
17 |
ENVIRONMENT/ECOLOGY |
10 |
1.28% |
8 |
1.07% |
|
|
合计 |
779 |
100.00% |
750 |
100.00% |
|
序号 |
2026年7月我校31篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
GLOBAL BURDEN OF 288 CAUSES OF DEATH AND LIFE EXPECTANCY DECOMPOSITION IN 204 COUNTRIES AND TERRITORIES AND 811 SUBNATIONAL LOCATIONS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2100-2132 MAY 18 2024 |
10.1016/S0140-6736(24)00367-2 |
CLINICAL MEDICINE |
1928 |
|
2 |
GLOBAL BURDEN AND STRENGTH OF EVIDENCE FOR 88 RISK FACTORS IN 204 COUNTRIES AND 811 SUBNATIONAL LOCATIONS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2162-2203 MAY 18 2024 |
10.1016/S0140-6736(24)00933-4 |
CLINICAL MEDICINE |
1892 |
|
3 |
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF STROKE AND ITS RISK FACTORS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET NEUROLOGY 23 (10): 973-1003 OCT 2024 |
10.1016/S1474-4422(24)00369-7 |
NEUROSCIENCE & BEHAVIOR |
836 |
|
4 |
USING CLUSTERPROFILER TO CHARACTERIZE MULTIOMICS DATA |
NATURE PROTOCOLS 19 (11): - NOV 2024 |
10.1038/s41596-024-01020-z |
BIOLOGY & BIOCHEMISTRY |
705 |
|
5 |
BURDEN OF DISEASE SCENARIOS FOR 204 COUNTRIES AND TERRITORIES, 2022-2050: A FORECASTING ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2204-2256 MAY 18 2024 |
10.1016/S0140-6736(24)00685-8 |
CLINICAL MEDICINE |
639 |
|
6 |
GLOBAL, REGIONAL, AND NATIONAL PREVALENCE OF ADULT OVERWEIGHT AND OBESITY, 1990-2021, WITH FORECASTS TO 2050: A FORECASTING STUDY FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 405 (10481): 813-838 MAR 8 2025 |
10.1016/S0140-6736(25)00355-1 |
CLINICAL MEDICINE |
592 |
|
7 |
GLOBAL FERTILITY IN 204 COUNTRIES AND TERRITORIES, 1950-2021, WITH FORECASTS TO 2100: A COMPREHENSIVE DEMOGRAPHIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2057-2099 MAY 18 2024 |
10.1016/S0140-6736(24)00550-6 |
CLINICAL MEDICINE |
301 |
|
8 |
OSTEOARTHRITIS |
NATURE REVIEWS DISEASE PRIMERS 11 (1): - FEB 13 2025 |
10.1038/s41572-025-00594-6 |
CLINICAL MEDICINE |
234 |
|
9 |
MACROPHAGES IN CARDIOVASCULAR DISEASES: MOLECULAR MECHANISMS AND THERAPEUTIC TARGETS |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 9 (1): - MAY 31 2024 |
10.1038/s41392-024-01840-1 |
MOLECULAR BIOLOGY & GENETICS |
224 |
|
10 |
GLOBAL BURDEN OF METABOLIC DISEASES, 1990-2021021 |
METABOLISM-CLINICAL AND EXPERIMENTAL 160: - NOV 2024 |
10.1016/j.metabol.2024.155999 |
BIOLOGY & BIOCHEMISTRY |
206 |
|
11 |
TISSUE MACROPHAGES: ORIGIN, HETEROGENITY, BIOLOGICAL FUNCTIONS, DISEASES AND THERAPEUTIC TARGETS |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 10 (1): - MAR 7 2025 |
10.1038/s41392-025-02124-y |
MOLECULAR BIOLOGY & GENETICS |
204 |
|
12 |
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF CARDIOVASCULAR DISEASES AND RISK FACTORS IN 204 COUNTRIES AND TERRITORIES, 1990-2023 |
JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 86 (22): 2167-2243 DEC 2 2025 |
10.1016/j.jacc.2025.08.015 |
CLINICAL MEDICINE |
187 |
|
13 |
TRANSARTERIAL CHEMOEMBOLISATION COMBINED WITH LENVATINIB PLUS PEMBROLIZUMAB VERSUS DUAL PLACEBO FOR UNRESECTABLE, NON-METASTATIC HEPATOCELLULAR CARCINOMA (LEAP-012) : A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY |
LANCET 405 (10474): 203-215 JAN 18 2025 |
10.1016/S0140-6736(24)02575-3 |
CLINICAL MEDICINE |
184 |
|
14 |
A METALLIC ROOM-TEMPERATURE D-WAVE ALTERMAGNET |
NATURE PHYSICS 21 (5): - MAY 2025 |
10.1038/s41567-025-02822-y |
PHYSICS |
148 |
|
15 |
GLOBAL BURDEN OF 292 CAUSES OF DEATH IN 204 COUNTRIES AND TERRITORIES AND 660 SUBNATIONAL LOCATIONS, 1990-2023: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2023 |
LANCET 406 (10513): 1811-1872 OCT 18 2025 |
10.1016/S0140-6736(25)01917-8 |
CLINICAL MEDICINE |
145 |
|
16 |
TREATMENT ALGORITHM FOR PULMONARY ARTERIAL HYPERTENSION |
EUROPEAN RESPIRATORY JOURNAL 64 (4): - OCT 2024 |
10.1183/13993003.01325-2024 |
CLINICAL MEDICINE |
118 |
|
17 |
BURDEN OF 375 DISEASES AND INJURIES, RISK-ATTRIBUTABLE BURDEN OF 88 RISK FACTORS, AND HEALTHY LIFE EXPECTANCY IN 204 COUNTRIES AND TERRITORIES, INCLUDING 660 SUBNATIONAL LOCATIONS, 1990-2023: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2023 |
LANCET 406 (10513): 1873-1922 OCT 18 2025 |
10.1016/S0140-6736(25)01637-X |
CLINICAL MEDICINE |
88 |
|
18 |
MESENCHYMAL STEM CELLS IN TREATING HUMAN DISEASES: MOLECULAR MECHANISMS AND CLINICAL STUDIES |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 10 (1): - AUG 22 2025 |
10.1038/s41392-025-02313-9 |
MOLECULAR BIOLOGY & GENETICS |
86 |
|
19 |
ADVANCES IN ANTIMICROBIAL PEPTIDES: FROM MECHANISTIC INSIGHTS TO CHEMICAL MODIFICATIONS |
BIOTECHNOLOGY ADVANCES 81: - JUL-AUG 2025 |
10.1016/j.biotechadv.2025.108570 |
BIOLOGY & BIOCHEMISTRY |
56 |
|
20 |
GLOBAL AGE-SEX-SPECIFIC ALL-CAUSE MORTALITY AND LIFE EXPECTANCY ESTIMATES FOR 204 COUNTRIES AND TERRITORIES AND 660 SUBNATIONAL LOCATIONS, 1950-2023: A DEMOGRAPHIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2023 |
LANCET 406 (10513): 1731-1810 OCT 18 2025 |
10.1016/S0140-6736(25)01330-3 |
CLINICAL MEDICINE |
45 |
|
21 |
NATURAL KILLER CELL IMMUNE CHECKPOINTS AND THEIR THERAPEUTIC TARGETING IN CANCER TREATMENT |
RESEARCH 8: - JUN 3 2025 |
10.34133/research.0723 |
IMMUNOLOGY |
43 |
|
22 |
INTEGRATED SINGLE-CELL AND SPATIAL TRANSCRIPTOMICS UNCOVER DISTINCT CELLULAR SUBTYPES INVOLVED IN NEURAL INVASION IN PANCREATIC CANCER |
CANCER CELL 43 (9): - SEP 8 2025 |
10.1016/j.ccell.2025.06.020 |
MOLECULAR BIOLOGY & GENETICS |
40 |
|
23 |
GLOBAL, REGIONAL, AND NATIONAL TRENDS IN ROUTINE CHILDHOOD VACCINATION COVERAGE FROM 1980 TO 2023 WITH FORECASTS TO 2030: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2023 |
LANCET 406 (10500): 235-260 JUL 15 2025 |
10.1016/S0140-6736(25)01037-2 |
CLINICAL MEDICINE |
39 |
|
24 |
ERADICATING FUNGAL BIOFILM-BASED INFECTIONS BY ULTRASOUND-ASSISTED SEMICONDUCTOR SENSITIZED UPCONVERSION PHOTODYNAMIC THERAPY |
NATURE COMMUNICATIONS 16 (1): - JUL 15 2025 |
10.1038/s41467-025-61519-1 |
CHEMISTRY |
37 |
|
25 |
METABOLIC REPROGRAMMING IN LUNG CANCER: HALLMARKS, MECHANISMS, AND TARGETED STRATEGIES TO OVERCOME IMMUNE RESISTANCE |
CANCER MEDICINE 14 (21): - OCT 29 2025 |
10.1002/cam4.71317 |
CLINICAL MEDICINE |
27 |
|
26 |
ENGINEERED AGGREGATION-INDUCED EMISSION LUMINOGENS-BASED FRAMEWORK WITH CO-RELEASING PROPERTY FOR ACCELERATING DIABETIC WOUND HEALING |
CHEMICAL ENGINEERING JOURNAL 524: - NOV 15 2025 |
10.1016/j.cej.2025.168981 |
ENGINEERING |
25 |
|
27 |
METABOLIC REPROGRAMMING SIGNATURE PREDICTS IMMUNOTHERAPY EFFICACY IN LUNG ADENOCARCINOMA: TARGETING SLC25A1 TO OVERCOME IMMUNE RESISTANCE |
CHINESE JOURNAL OF CANCER RESEARCH 37 (6): - DEC 2025 |
10.21147/j.issn.1000-9604.2025.06.11 |
CLINICAL MEDICINE |
23 |
|
28 |
EFFECT OF HYPERTENSION ON LONG-TERM ADVERSE CLINICAL OUTCOMES AND LIVER FIBROSIS PROGRESSION IN MASLD |
JOURNAL OF HEPATOLOGY 84 (2): 254-265 FEB 2026 |
10.1016/j.jhep.2025.08.017 |
CLINICAL MEDICINE |
22 |
|
29 |
CURRENT CONCERNS AND FUTURE DIRECTIONS OF LARGE LANGUAGE MODEL CHATGPT IN MEDICINE: A MACHINE-LEARNING-DRIVEN GLOBAL-SCALE BIBLIOMETRIC ANALYSIS |
INTERNATIONAL JOURNAL OF SURGERY 112 (2): 2805-2822 FEB 2026 |
10.1097/JS9.0000000000003668 |
CLINICAL MEDICINE |
16 |
|
30 |
COMPARATIVE PERFORMANCE OF LARGE LANGUAGE MODELS FOR PATIENT-INITIATED OPHTHALMOLOGY CONSULTATIONS |
FRONTIERS IN PUBLIC HEALTH 13: - SEP 22 2025 |
10.3389/fpubh.2025.1673045 |
SOCIAL SCIENCES, GENERAL |
8 |
|
31 |
AUTOCRINE SFRP2 (SECRETED FRIZZLED RELATED PROTEIN 2) ENHANCES LUNG MYOFIBROBLAST FIBROGENIC ACTIVITY BY SUPPRESSING PINK1-MEDIATED MITOPHAGY INITIATION |
AUTOPHAGY 22 (6): 1333-1350 JUN 3 2026 |
10.1080/15548627.2026.2642341 |
MOLECULAR BIOLOGY & GENETICS |
6 |
